Posted on 03/23/2010 7:41:52 PM PDT by Chet 99
Last updated at 1:41 PM on 23rd March 2010
Three cancer patient support groups today announced they are appealing a decision to reject a drug used to treat a range of bone marrow disorders for use on the NHS.
The National Institute for Health and Clinical Excellence (Nice) ruled in draft guidance earlier this month that azacitidine - or Vidaza - could not be prescribed on the NHS for the treatment of a number of myelodysplastic syndromes (MDS).
MDS UK Patient Support Group, The Leukaemia Society and the Rarer Cancers Forum are all appealing against the Nice guidance.
(Excerpt) Read more at dailymail.co.uk ...
Could it be just the beginning of ghoulish plans? Could it be by design and on purpose???????
More shovel-ready stimulus projects for the UK.
Coming to a doctor’s office near you in the good ol’ USA!
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.